Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

You’re on our free ad-supported tier. Upgrade to NewsNow Essentials for just £4/m now! Your favourite news platform, faster, slicker and ad free.You’re on our free tier. Get NewsNow Essentials at just £4/m now!. Faster, slicker and ad free.You’re on our free tier. Go ad free for just £4/m now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
AI
Business
Football
Sport
Entertainment
Tech
Science

AstraZeneca
Pharmaceuticals
GSK
Novartis
Novo Nordisk
Sanofi
Johnson and Johnson
Takeda
Bristol Myers Squibb
Topics

Advertisement

Advertisement

AstraZeneca

Share

Top Latest Popular

NewsNow Essentials. Better browsing, ad free. Just £4/m, billed annually. Upgrade now!

NewsNow Essentials. Your favourite news platform, ad free. £4/m, billed annually. Upgrade now!

Yesterday

AstraZeneca-Daiichi get nod for NHS to use breast cancer drug in England Times LIVE 15:00 Thu, 17 Sep

Big Picture Bio Founded to Identify, Design and Optimise Promising Cancer Combination Therapies Business Wire (Press Release) 14:06 Thu, 17 Sep

AstraZeneca's Enhertu Gets Nice Recommendation For HER2 Low Metastatic Breast Cancer RTT News 13:54 Thu, 17 Sep

Advertisement

Advertisement

First-Line Enhertu Delayed HER2-Mutant Lung Cancer Progression by Six Months Over Keytruda Plus Chemotherapy, but Survival Remains Unsettled Medical Daily 13:24 Thu, 17 Sep

The City analysts tipping AstraZeneca shares to rise again interactive investor 10:05 Thu, 17 Sep

STAT Plus: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal STAT 08:50 Thu, 17 Sep

AstraZeneca Malaysia, MSN Society join Forces To Strengthen Awareness Of Rare aHUS Bernama 07:26 Thu, 17 Sep

Independent Chairman of AstraZeneca Michel Demare Buys 25% More Shares Simply Wall St 06:58 Thu, 17 Sep

Innate Pharma Reports First Half 2026 Business Update and Financial Results Business Wire (Press Release) 06:03 Thu, 17 Sep

Wednesday

AstraZeneca shares oversold after trial flops and merger talk, says UBS Proactive Investors (US) 15:48 Wed, 16 Sep

Is It Worth Investing in Astrazeneca (AZN) Based on Wall Street's Bullish Views? Zacks 15:38 Wed, 16 Sep

AstraZeneca's news flow next year could sustain drugs group beyond 2030, says leading bank Proactive Investors (US) 12:05 Wed, 16 Sep

Tuesday

Broker tips: GSK, Astrazeneca, Vodafone ShareCast 16:08 Tue, 15 Sep

Deutsche Bank upgrades Astrazeneca to 'hold' ShareCast 14:16 Tue, 15 Sep

AstraZeneca, Leidos, Expeditors International And More On CNBC’s ‘Final Trades’ Benzinga 12:47 Tue, 15 Sep

AstraZeneca’s cancer pipeline posts two wins and a loss Clinical Trials Arena 09:52 Tue, 15 Sep

Why the Market Dipped But Astrazeneca (AZN) Gained Today Zacks 00:15 Tue, 15 Sep

Advertisement

Monday

Astrazeneca’s Etcamah misses in first-line breast cancer study BioWorld 21:47 Mon, 14 Sep

No Surprise As SERENA-4 Serves Up A Miss For AstraZeneca’s Etcamah Scrip Pharma Intelligence 16:29 Mon, 14 Sep

STAT Plus: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and more STAT 14:13 Mon, 14 Sep

Susan G. Komen® and AstraZeneca Partnership to Make Patient Navigation Available to All Business Wire (Press Release) 14:04 Mon, 14 Sep

Why Is AstraZeneca Stock Trading Higher Today? Benzinga 13:48 Mon, 14 Sep

AstraZeneca breast cancer drug fails trial but Citi keeps 'buy' rating Proactive Investors (US) 13:08 Mon, 14 Sep

AstraZeneca’s Tagrisso shows eight-year landmark survival in early-stage EGFR-mutated lung cancer PMLiVE 13:01 Mon, 14 Sep

AZ's Etcamah falls short in first-line breast cancer trial pharmaphorum 12:56 Mon, 14 Sep

AstraZeneca's Tagrisso Achieves 8-Year Survival Milestone In Early-Stage EGFR- Mutated Lung Cancer RTT News 10:35 Mon, 14 Sep

Astrazeneca's Etcamah trial fails to meet primary endpoint ShareCast 10:15 Mon, 14 Sep

Enhertu demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTINY-Lung04 Phase III trial AstraZeneca (Press Release) 02:56 Mon, 14 Sep

Tagrisso demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial AstraZeneca (Press Release) 02:56 Mon, 14 Sep

Tagrisso® (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in Adaura Phase III trial Business Wire (Press Release) 02:52 Mon, 14 Sep

Saturday

AstraZeneca's breast cancer drug fails in late-stage trial The Times of India 12:02 Sat, 12 Sep

STAT Plus: Breast cancer pill from AstraZeneca misses mark in pivotal trial STAT 08:17 Sat, 12 Sep

AstraZeneca’s breast cancer pill fails in a late-stage trial Times LIVE 07:24 Sat, 12 Sep

In the last month

AstraZeneca Says Breast Cancer Pill Fails in Key Study Bloomberg Law 22:58 Fri, 11 Sep

Update on SERENA-4 Phase III trial of Etcamah in combination with palbociclib in upfront 1st-line advanced ER-positive breast cancer AstraZeneca (Press Release) 21:24 Fri, 11 Sep

AstraZeneca shares phase 3 results for Imfinzi plus Imdelltra in extensive-stage small cell lung cancer PMLiVE 10:58 Fri, 11 Sep

Obesity Market Set for Explosive 27% CAGR Growth by 2036, Fueled by 7 Promising Emerging Therapies | DelveInsight PR Newswire (Press Release) 15:31 Thu, 10 Sep

AstraZeneca's $5bn drug promise is no 'buy' signal for Deutsche Proactive Investors (UK) 13:32 Thu, 10 Sep

Experimental AstraZeneca Drug Reduces COPD Flare-Ups in Late-Stage Trials HumanProgress 22:13 Wed, 09 Sep

Amgen's Imdelltra scores again in small cell lung cancer pharmaphorum 14:26 Wed, 09 Sep

Advertisement

My Local News

Advertisement

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis